RWE4Decisions Annual Symposium
On 25 November 2022
At : Brussels, Belgium
Events
ITINERARE Symposium 2022
On 02 December 2022
At : Zurich, Switzerland
International Conference on Clinical Research Networks for Rare Diseases
From 02 to 03 December 2022
At : Paris, France
CLINICAL TRIALS IN RARE DISEASES : A VIRTUAL EVENT
On 08 December 2022
At : Online
Third International Summit on Human Genome Editing
From 07 to 09 March 2023
At : London, United Kingdom
2023 RE(ACT) Congress & IRDiRC Conference
From 16 to 19 March 2023
At : Berlin, Germany
EJP RD – ERN Workshop: New Therapeutical Approaches for Inherited Retinal Dystrophies
From 28 to 29 March 2023
At : Valencia, Spain
In the context of EJP RD’s ERN Workshops, a face-to-face workshop entitled “EJP RD – ERN Workshop: New Therapeutical Approaches for Inherited Retinal Dystrophies” is being organized by Dr Regina Rodrigo.
The in-person event will take place on 27-28 March 2023 at CIPF – Príncipe Felipe Research Center, Eduardo Primo Yúfera, 3, 46012, Valencia, Spain.
Registration is open here, and closes on December 31st.
The workshop, open for beginners and medium level researchers – junior physicians and scientists, will give an update on basic and translational research related to new therapeutic approaches for IRDs. It will bring together European experts and trainees to improve the training of young researchers on IRDs and latest therapies. Participants and speakers will involve representatives from ERN-EYE partners and non-ERN-EYE partners.
More information here
Rare Genetic Neurodevelopmental Disorders: EuroNDD 2023
From 21 to 22 April 2023
At : Amsterdam
The Translational Science of Rare Diseases - From Rare to Care IV
From 04 to 06 May 2023
At : Tutzing, Germany
Grants
New grant from NORD
NORD has announced a $70,000 in grant funding for rare disease research. Grants will be awarded to qualified researchers to initiate small research studies or clinical trials, which could be used to obtain funding from NIH, FDA, or other agencies; or to attract a corporate sponsor. Three grants are available for research on Levy-Yeboa syndrome (LYS), megacystis microcolon intestinal hypoperistalsis syndrome (MMIHS), and autoimmune polyglandular syndrome type 1 (APS-1).
FDA funding opportunity for rare disease research
The Food and Drug Administration’s (FDA) Office of Orphan Products Development (OOPD) has announced a grant to support efficient and innovative natural history studies that advance medical product development in rare diseases with unmet needs. The funding opportunity announcement is entitled “Efficient and Innovative Natural History Studies Addressing Unmet Needs in Rare Diseases (R01) Clinical Trials Not Required”. The purpose of this grant is to address critical knowledge gaps and facilitate rare disease product development.
The receipt dates for this funding opportunity are 15 February 2022 and 13 February 2024.
Courses and educational initiatives
The 6th edition of Duchenne Patient Academy
The 6th edition of Duchenne Patient Academy will take place on December 1 – 3 2022. This edition's theme is ‘Changing Perspectives’. The Academy provides online training for Duchenne and Becker muscular dystrophy (DMD/BMD) patient advocates. Over the course of 3 days, Duchenne Patient Academy 2022 attendees will listen to speakers and attend panel discussions moderated by experts in their respective fields. As with last year, attendees have the opportunity to become involved in the dialogue and share their experiences.
EJPRD free and online MOOC on Diagnosing Rare Diseases: New Facilitation Window
The French Foundation for Rare Diseases is delighted to announce the upcoming opening of a new facilitation window of the MOOC "Diagnosing Rare Diseases: from the Clinic to Research and back". Mentors, experts in the field, will be available online to respond to you as you progress through the MOOC.
In the context of European Joint Programme on Rare Diseases (EJP RD), the French Foundation For Rare Diseases, ERN Ithaca and ERN Genturis have co-developed this MOOC.
The goal of the course is to learn about rare genetic disease diagnosis and testing, to understand the impact of technology in diagnostic research and to gain insights into patients’ experiences of rare genetic disease.
This course is designed for individuals with a keen interest in diagnostic research and rare diseases. While primarily designed for medical students and PhD/post-doc students in biomedical sciences, it will also be of interest to Patients Advocacy Organisations’ representatives, Healthcare professionals or paramedics who want to further their knowledge of rare diseases diagnosis.
4th Neuromuscular Translational School
The Neuromuscular Translational School, organised by EURO-NMD and TREAT-NMD, focuses on therapy development from bench to bedside with a focus on neuromuscular disorders. The Translational School contains lectures about the current state of the art of acquired and genetic neuromuscular diseases, the different steps of drug development and the tools needed for this (outcome measures, biomarkers etc.). It also stresses how patients should play a role in these steps and teaches how to communicate research to patients and the general public during interactive workshop sessions.
The Translational School will take place in autumn this year from November 21-25 in Leiden University Medical Center, the Netherlands.
RareLaunch programme
NORD’s RareLaunch programme provides an accessible educational platform that allows an individual to explore the steps to start a nonprofit and/or to engage in starting or expanding research efforts as a nonprofit leader. Twi courses are available, Forming a Foundation and Research Ready. Forming a Foundation provides education and training for interested patients and caregivers looking to form rare-disease-focused nonprofits. Research Ready supports the efforts of patient organizations to effectively prepare for scientific research and the creation of rare disease registries. Both courses emphasize capacity building and expanding confidence at a pivotal stage in a rare disease community’s growth and development.
EJP RD Funded ERN Training Workshops
The EJP-RD is holding workshops aiming at training ERN researchers and clinicians in relevant innovative themes with a cross-ERN added value. These 2-days ERN workshops are open to interested persons (clinicians/scientists) affiliated to ERNs or Affiliated Partner Institutions.
Training themes may include innovative research methodologies, diagnostic research methodologies, interdisciplinary treatment approaches, such as gene therapy and transplantation, etc. Topics have to be proposed by the ERNs or by investigators belonging to EJP RD beneficiary institutions. Registrations are now open for several workshops.
ERN EpiCare e-learning modules
The ERN EpiCARE has developped new e-learning modules in collaboration with the ILAE Academy. The modules are dedicated towards professionals who wish to practice diagnosis of rare and complex epilepsies. The first online six modules are patient-centered cases.
Job opportunities
Policy and Communication Officer
Please send your CV and cover letter to:
jobs.orphanet@inserm.fr
Administrative Assistant
Please send your CV and cover letter to:
jobs.orphanet@inserm.fr
Scientific Project Manager, Medical terminology for rare diseases
Please send your CV and cover letter to:
jobs.orphanet@inserm.fr
Team Leader, Coordination of the rare disease experts international database
Please send your CV and cover letter to:
jobs.orphanet@inserm.fr
ERN EURO-NMD: Two job vacancies
*
Two job vacancies are now available with the ERN Euro-NMD. More details below.